cached image

Ahmad Salehi, M.D, Ph.D. - Publications

Affiliations: 
Psychiatry Stanford Medical School/Palo Alto VA 
Area:
Alzheimer's disease, Down syndrome, NGF, Axonal transport
Website:
http://www.ahmadsalehi.info

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Jones RC, Karkanias J, Krasnow MA, Pisco AO, Quake SR, Salzman J, Yosef N, Bulthaup B, Brown P, Harper W, Hemenez M, Ponnusamy R, Salehi A, Sanagavarapu BA, Spallino E, et al. The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans. Science (New York, N.Y.). 376: eabl4896. PMID 35549404 DOI: 10.1126/science.abl4896  0.673
2021 Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG, Doran E, Head E, Yu YE, Mobley WC. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34757693 DOI: 10.1002/alz.12463  0.672
2021 Swaab DF, Buijs RM, Kreier F, Lucassen PJ, Salehi A. Preface. Handbook of Clinical Neurology. 182: ix-xi. PMID 34266616 DOI: 10.1016/B978-0-12-819973-2.09997-4  0.581
2021 Swaab DF, Buijs RM, Kreier F, Lucassen PJ, Salehi A. Introduction: The human hypothalamus and neuropsychiatric disorders. Handbook of Clinical Neurology. 182: 1-5. PMID 34266586 DOI: 10.1016/B978-0-12-819973-2.00001-0  0.601
2021 Swaab DF, Buijs RM, Lucassen PJ, Salehi A, Kreier F. Introduction: The human hypothalamus and neuroendocrine disorders. Handbook of Clinical Neurology. 181: 1-5. PMID 34238450 DOI: 10.1016/B978-0-12-820683-6.00001-4  0.598
2021 Swaab DF, Kreier F, Lucassen PJ, Salehi A, Buijs RM. Preface. Handbook of Clinical Neurology. 179: ix-xi. PMID 34225988 DOI: 10.1016/B978-0-12-819975-6.09987-8  0.581
2021 Swaab DF, Buijs RM, Kreier F, Lucassen PJ, Salehi A. Introduction: The anterior hypothalamus. Handbook of Clinical Neurology. 179: 3-5. PMID 34225970 DOI: 10.1016/B978-0-12-819975-6.00014-5  0.585
2021 Fahimi A, Noroozi M, Salehi A. Enlargement of early endosomes and traffic jam in basal forebrain cholinergic neurons in Alzheimer's disease. Handbook of Clinical Neurology. 179: 207-218. PMID 34225963 DOI: 10.1016/B978-0-12-819975-6.00011-X  0.349
2021 Swaab DF, Kreier F, Lucassen PJ, Salehi A, Buijs RM. Introduction: The middle and posterior hypothalamus. Handbook of Clinical Neurology. 180: 1-4. PMID 34225923 DOI: 10.1016/B978-0-12-820107-7.00001-X  0.583
2020 Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32975365 DOI: 10.1002/alz.12185  0.675
2018 Madasamy S, Lundry J, Abrea A, Mathur S, Shanmugavel S, Kong R, Alderete B, Robinson JP, Ponnusamy R, Salehi A, Mufson EJ, Wu A. P3-253: In Vitro Serum Amyloid Particle Formation Propensity: Alzheimer'S Disease Biomarker Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1613  0.728
2017 Ponnusamy R, McNerney W, Moghadam S, Salehi A. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease. Brain Research. PMID 29102776 DOI: 10.1016/J.Brainres.2017.09.035  0.774
2017 Helm S, Blayney M, Whited T, Noroozi M, Lin S, Kern S, Green D, Salehi A. Deleterious Effects of Chronic Folate Deficiency in the Ts65Dn Mouse Model of Down Syndrome. Frontiers in Cellular Neuroscience. 11: 161. PMID 28649192 DOI: 10.3389/Fncel.2017.00161  0.377
2016 Mojabi FS, Fahimi A, Moghadam S, Moghadam S, McNerneny MW, Ponnusamy R, Kleschevnikov A, Mobley WC, Salehi A. GABAergic Hyperinnervation of Dentate Granule Cells in the Ts65Dn Mouse Model of Down Syndrome Exploring the Role of App. Hippocampus. PMID 27701794 DOI: 10.1002/Hipo.22664  0.789
2016 Fahimi A, Baktir MA, Moghadam S, Mojabi FS, Sumanth K, McNerney MW, Ponnusamy R, Salehi A. Physical exercise induces structural alterations in the hippocampal astrocytes: exploring the role of BDNF-TrkB signaling. Brain Structure & Function. PMID 27686571 DOI: 10.1007/S00429-016-1308-8  0.78
2016 Phillips C, Fahimi A, Das D, Mojabi FS, Ponnusamy R, Salehi A. Noradrenergic system in down syndrome and Alzheimer’s disease a target for therapy Current Alzheimer Research. 13: 68-83.  0.429
2015 Salehi A, Ashford JW, Mufson EJ. Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective. Current Alzheimer Research. PMID 26487155 DOI: 10.2174/1567205012999151021102914  0.394
2015 Phillips C, Fahimi A, Das D, Mojabi FS, Ponnusamy R, Salehi A. Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy. Current Alzheimer Research. PMID 26391048 DOI: 10.2174/1567205012666150921095924  0.806
2015 Das D, Medina B, Baktir MA, Mojabi FS, Fahimi A, Ponnusamy R, Salehi A. Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome. Neuroscience Letters. 604: 91-6. PMID 26240993 DOI: 10.1016/J.Neulet.2015.07.040  0.791
2015 Das D, Phillips C, Lin B, Mojabi F, Akif Baktir M, Dang V, Ponnusamy R, Salehi A. Assessment of dendritic arborization in the dentate gyrus of the hippocampal region in mice. Journal of Visualized Experiments : Jove. PMID 25867799 DOI: 10.3791/52371  0.772
2015 Nosheny RL, Belichenko PV, Busse BL, Weissmiller AM, Dang V, Das D, Fahimi A, Salehi A, Smith SJ, Mobley WC. Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiology of Disease. 77: 173-90. PMID 25753471 DOI: 10.1016/J.Nbd.2015.02.022  0.788
2015 Phillips C, Akif Baktir M, Das D, Lin B, Salehi A. The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease. Physical Therapy. 95: 1046-60. PMID 25573757 DOI: 10.2522/Ptj.20140212  0.573
2015 Das D, Medina B, Baktir MA, Mojabi FS, Fahimi A, Ponnusamy R, Salehi A. Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome Neuroscience Letters. 604: 91-96. DOI: 10.1016/j.neulet.2015.07.040  0.707
2014 Heller HC, Salehi A, Chuluun B, Das D, Lin B, Moghadam S, Garner CC, Colas D. Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors. Neurobiology of Learning and Memory. 116: 162-71. PMID 25463650 DOI: 10.1016/J.Nlm.2014.10.002  0.702
2014 Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D, Salehi A. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neuroscience and Biobehavioral Reviews. 47: 336-58. PMID 25218759 DOI: 10.1016/J.Neubiorev.2014.08.017  0.478
2014 Phillips C, Baktir MA, Srivatsan M, Salehi A. Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Frontiers in Cellular Neuroscience. 8: 170. PMID 24999318 DOI: 10.3389/Fncel.2014.00170  0.367
2014 Das D, Phillips C, Hsieh W, Sumanth K, Dang V, Salehi A. Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 140-8. PMID 24842803 DOI: 10.1016/J.Pnpbp.2014.05.004  0.746
2014 Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome. Biological Psychiatry. 75: 179-88. PMID 23827853 DOI: 10.1016/J.Biopsych.2013.05.024  0.801
2014 Salehi A, Dang V, Das D. Neurobiological Basis of Cognitive Dysfunction in Down Syndrome and Alzheimer's Disease Neurobiology of Aging. 35: 719. DOI: 10.1016/J.Neurobiolaging.2013.10.051  0.689
2013 Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care. Neuroscience and Biobehavioral Reviews. 37: 1363-79. PMID 23707776 DOI: 10.1016/J.Neubiorev.2013.05.008  0.802
2012 Kleschevnikov AM, Belichenko PV, Salehi A, Wu C. Discoveries in Down syndrome: moving basic science to clinical care. Progress in Brain Research. 197: 199-221. PMID 22541294 DOI: 10.1016/B978-0-444-54299-1.00010-8  0.44
2012 Kleschevnikov AM, Belichenko PV, Gall J, George L, Nosheny R, Maloney MT, Salehi A, Mobley WC. Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome. Neurobiology of Disease. 45: 683-91. PMID 22062771 DOI: 10.1016/J.Nbd.2011.10.009  0.671
2012 Millan Sanchez M, Heyn SN, Das D, Moghadam S, Martin KJ, Salehi A. Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP. Biological Psychiatry. 71: 403-9. PMID 21945306 DOI: 10.1016/J.Biopsych.2011.08.016  0.764
2012 Das D, Sanchez M, Taylor J, Noda A, Yesavage J, Salehi A. BDNF Polymorphism Predicts the Rate of Decline in Skilled Task Performance and Hippocampal Volume in Healthy Individuals (P05.071) Neurology. 78: P05.071-P05.071. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.071  0.46
2011 Sanchez MM, Das D, Taylor JL, Noda A, Yesavage JA, Salehi A. BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Translational Psychiatry. 1: e51. PMID 22833197 DOI: 10.1038/Tp.2011.47  0.509
2011 Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A. Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy. Journal of Alzheimer's Disease : Jad. 26: 29-47. PMID 21971449 DOI: 10.3233/Jad-2011-0050  0.755
2011 Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, et al. Imaging the Alzheimer brain. Journal of Alzheimer's Disease : Jad. 26: 1-27. PMID 21971448 DOI: 10.3233/Jad-2011-0073  0.363
2011 Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A. Hippocampal network alterations in Alzheimer's disease and downsyndrome: From structure to therapy Advances in Alzheimer's Disease. 2: 11-29. DOI: 10.3233/978-1-60750-793-2-11  0.585
2009 Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, Mobley WC. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Science Translational Medicine. 1: 7ra17. PMID 20368182 DOI: 10.1126/Scitranslmed.3000258  0.687
2009 Tamaki SJ, Jacobs Y, Dohse M, Capela A, Cooper JD, Reitsma M, He D, Tushinski R, Belichenko PV, Salehi A, Mobley W, Gage FH, Huhn S, Tsukamoto AS, Weissman IL, et al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell. 5: 310-9. PMID 19733542 DOI: 10.1016/J.Stem.2009.05.022  0.681
2009 Honda M, Arai T, Fukazawa M, Honda Y, Tsuchiya K, Salehi A, Akiyama H, Mignot E. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology. 73: 511-7. PMID 19687452 DOI: 10.1212/Wnl.0B013E3181B2A6Af  0.353
2009 Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM, Mount HT, Mufson EJ, Salehi A, Fahnestock M. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9321-9. PMID 19625522 DOI: 10.1523/Jneurosci.4736-08.2009  0.367
2009 Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5938-48. PMID 19420260 DOI: 10.1523/Jneurosci.1547-09.2009  0.689
2009 Honda M, Eriksson KS, Zhang S, Tanaka S, Lin L, Salehi A, Hesla PE, Maehlen J, Gaus SE, Yanagisawa M, Sakurai T, Taheri S, Tsuchiya K, Honda Y, Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). Plos One. 4: e4254. PMID 19158946 DOI: 10.1371/Journal.Pone.0004254  0.362
2009 Belichenko PV, Kleschevnikov AM, Masliah E, Wu C, Takimoto-Kimura R, Salehi A, Mobley WC. Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. The Journal of Comparative Neurology. 512: 453-66. PMID 19034952 DOI: 10.1002/Cne.21895  0.669
2008 Salehi A, Faizi M, Takimoto R, Valletta J, Danks A, Mobley WC. P2-308: Examining the effects of (+)-phenserine in Ts65Dn mouse model of down syndrome Alzheimer's & Dementia. 4: T462-T463. DOI: 10.1016/J.Jalz.2008.05.1385  0.652
2007 Salehi A, Faizi M, Belichenko PV, Mobley WC. Using mouse models to explore genotype-phenotype relationship in Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews. 13: 207-14. PMID 17910089 DOI: 10.1002/Mrdd.20164  0.68
2007 Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. The Journal of Comparative Neurology. 504: 329-45. PMID 17663443 DOI: 10.1002/Cne.21433  0.682
2007 Salehi A, Kleshevnikov A, Mobley WC. Cholinergic neurodegeneration in Alzheimer's disease: Basis for nerve growth factor therapy Pharmacological Mechanisms in Alzheimer's Therapeutics. 64-104. DOI: 10.1007/978-0-387-71522-3_5  0.628
2006 Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 51: 29-42. PMID 16815330 DOI: 10.1016/J.Neuron.2006.05.022  0.716
2006 Fahnestock M, Garzon D, Peng S, Flood D, Salehi A, Mount HTJ. P1-032: Decreased BDNF mRNA levels in mouse models of Alzheimer’s disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.407  0.307
2004 Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. The Journal of Comparative Neurology. 480: 281-98. PMID 15515178 DOI: 10.1002/Cne.20337  0.687
2004 Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 323-45. PMID 14991458 DOI: 10.1007/S00702-003-0091-X  0.63
2004 Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD, Belichenko PV, Salehi A, Mobley WC. Trafficking the NGF signal: implications for normal and degenerating neurons. Progress in Brain Research. 146: 3-23. PMID 14699953 DOI: 10.1016/S0079-6123(03)46001-9  0.735
2004 Salehi A, Delcroix J, Xia W, Sambamurti K, Mobley WC. P1-254 APP and β-amyloid levels in segmental trisomy mouse model of down syndrome Neurobiology of Aging. 25: S168. DOI: 10.1016/S0197-4580(04)80567-0  0.652
2004 Delcroix J, Salehi A, Mobley W. S4-01-03 Trafficking the target-derived signals of neurotrophic factors: implications for normal and degenerating neurons Neurobiology of Aging. 25: S67. DOI: 10.1016/S0197-4580(04)80227-6  0.66
2003 Salehi A, Delcroix JD, Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends in Neurosciences. 26: 73-80. PMID 12536130 DOI: 10.1016/S0166-2236(02)00038-3  0.675
2002 Verwer RW, Hermens WT, Dijkhuizen P, ter Brake O, Baker RE, Salehi A, Sluiter AA, Kok MJ, Muller LJ, Verhaagen J, Swaab DF. Cells in human postmortem brain tissue slices remain alive for several weeks in culture. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 54-60. PMID 11772936 DOI: 10.1096/Fj.01-0504Com  0.571
2001 Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J, Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proceedings of the National Academy of Sciences of the United States of America. 98: 10439-44. PMID 11504920 DOI: 10.1073/Pnas.181219298  0.775
2000 van Leeuwen FW, Fischer DF, Kamel D, Sluijs JA, Sonnemans MA, Benne R, Swaab DF, Salehi A, Hol EM. Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiology of Aging. 21: 879-91. PMID 11124436 DOI: 10.1016/S0197-4580(00)00151-2  0.704
2000 Ishunina TA, Salehi A, Swaab DF. Sex- and age-related P75 neurotrophin receptor expression in the human supraoptic nucleus. Neuroendocrinology. 71: 243-51. PMID 10773744 DOI: 10.1159/000054542  0.575
2000 Salehi A, Ocampo M, Verhaagen J, Swaab DF. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Experimental Neurology. 161: 245-58. PMID 10683291 DOI: 10.1006/Exnr.1999.7252  0.625
2000 Salehi A, Cooper JD, Alonso MA, Swaab DF, Mobley WC. Neurotrophin receptors in Alzheimer brain and A mouse model of down syndrome Neurobiology of Aging. 21: 114. DOI: 10.1016/S0197-4580(00)82310-6  0.748
1999 Salehi A, Swaab DF. Diminished neuronal metabolic activity in Alzheimer's disease. Review article. Journal of Neural Transmission (Vienna, Austria : 1996). 106: 955-86. PMID 10599878 DOI: 10.1007/S007020050216  0.638
1999 Ishunina TA, Salehi A, Hofman MA, Swaab DF. Activity of vasopressinergic neurones of the human supraoptic nucleus is age- and sex-dependent. Journal of Neuroendocrinology. 11: 251-8. PMID 10223278 DOI: 10.1046/J.1365-2826.1999.00318.X  0.557
1998 Salehi A, Pool CW, Mulder M, Ravid R, Gonatas NK, Swaab DF. Activity of Hippocampal CA1 Neurons in Alzheimer's Disease is not Affected by the Presence of Adjacent Neuritic Plaques. Journal of Alzheimer's Disease : Jad. 1: 107-118. PMID 12214007 DOI: 10.3233/Jad-1998-1204  0.618
1998 Salehi A, Gonzalez Martinez V, Swaab DF. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiology of Aging. 19: 505-10. PMID 10192208 DOI: 10.1016/S0197-4580(98)00106-7  0.632
1998 Swaab DF, Lucassen PJ, Salehi A, Scherder EJ, van Someren EJ, Verwer RW. Reduced neuronal activity and reactivation in Alzheimer's disease. Progress in Brain Research. 117: 343-77. PMID 9932420 DOI: 10.1016/S0079-6123(08)64027-3  0.812
1998 Salehi A, Verhaagen J, Swaab DF. Neurotrophin receptors in Alzheimer's disease. Progress in Brain Research. 117: 71-89. PMID 9932402 DOI: 10.1016/S0079-6123(08)64009-1  0.64
1998 Salehi A, Dubelaar EJ, Mulder M, Swaab DF. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proceedings of the National Academy of Sciences of the United States of America. 95: 11445-9. PMID 9736756 DOI: 10.1073/Pnas.95.19.11445  0.628
1998 Salehi A, Bakker JM, Mulder M, Swaab DF. Limited effect of neuritic plaques on neuronal density in the hippocampal CA1 area of Alzheimer patients. Alzheimer Disease and Associated Disorders. 12: 77-82. PMID 9651135 DOI: 10.1097/00002093-199806000-00004  0.564
1998 Oleana VH, Salehi A, Swaab DF. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients. Neuroreport. 9: 1451-4. PMID 9631446 DOI: 10.1097/00001756-199805110-00037  0.597
1998 van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Köycü S, Ramdjielal RD, Salehi A, Martens GJ, Grosveld FG, Peter J, Burbach H, Hol EM. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science (New York, N.Y.). 279: 242-7. PMID 9422699 DOI: 10.1126/Science.279.5348.242  0.576
1998 Van Leeuwen F, Salehi A, Giger R, Holtmaat A, Verhaagen J, Eikelboom T, Verweij W, Top W. Neuronal degeneration and regeneration: From basic mechanisms to prospects for therapy - Proceedings of the 20th International Summer School of Brain Research, held at the Royal Netherlands Academy of Sciences, Amsterdam, The Netherlands from 25 to 29 August 1997: Preface Progress in Brain Research. 117: xi-xii.  0.589
1997 Lucassen PJ, Tilders FJ, Salehi A, Swaab DF. Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depression. Aging (Milan, Italy). 9: 48-50. PMID 9358882 DOI: 10.1007/Bf03339703  0.659
1997 Swaab DF, Salehi A. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. Journal of Neuropathology and Experimental Neurology. 56: 216. PMID 9034377  0.556
1996 Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75: 373-87. PMID 8931004 DOI: 10.1016/0306-4522(96)00273-4  0.636
1996 Swaab D, van de Nes J, Salehi A. 804 Hallmarks of Alzheimer's disease are independent phenomena Neurobiology of Aging. 17: S200. DOI: 10.1016/S0197-4580(96)80806-2  0.599
1996 Salehi A, Pool C, Gonatas N, Swaab D. 734 Decreased protein synthetic ability and the neuropathological hallmarks of Alzheimer's disease are independent phenomena Neurobiology of Aging. 17: S182. DOI: 10.1016/S0197-4580(96)80736-6  0.603
1995 Salehi A, Ravid R, Gonatas NK, Swaab DF. Decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. Journal of Neuropathology and Experimental Neurology. 54: 704-9. PMID 7666060 DOI: 10.1097/00005072-199509000-00013  0.603
1995 Salehi A, Van de Nes JA, Hofman MA, Gonatas NK, Swaab DF. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Research. 678: 28-39. PMID 7620896 DOI: 10.1016/0006-8993(95)00138-G  0.617
1995 Salehi A, Heyn S, Gonatas NK, Swaab DF. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neuroscience Letters. 193: 29-32. PMID 7566659 DOI: 10.1016/0304-3940(95)11659-K  0.63
1994 Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 59: 871-80. PMID 8058125 DOI: 10.1016/0306-4522(94)90291-7  0.706
1994 Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HB. Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease. Neurobiology of Aging. 15: 369-71; discussion 3. PMID 7936066 DOI: 10.1016/0197-4580(94)90037-X  0.702
1994 Lucassen PJ, Salehi A, Pool CW, Gonatas NK, Swaab DF. Activation of vasopressin neurons in aging and Alzheimer's disease. Journal of Neuroendocrinology. 6: 673-9. PMID 7894470 DOI: 10.1111/J.1365-2826.1994.Tb00634.X  0.705
Show low-probability matches.